Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 3/20 | 0.32 |
| ▸ | ADH1C | P00326 | 2/20 | 0.32 |
| ▸ | ADH1B | P00325 | 1/20 | 0.32 |
| ▸ | ADH4 | P08319 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2846023 | 0.97 | TDP1 (0.33) | TDP1 | |
| SCHEMBL14040112 | 0.76 | TDP1 (0.40) | ADH1AADH1CADH1BADH4TDP1 | |
| SCHEMBL1028163 | 0.76 | TDP1 (0.40) | ADH1AADH1CADH1BADH4TDP1 | |
| SCHEMBL1357779 | 0.75 | — | — | |
| SCHEMBL4669976 | 0.73 | TDP1 (0.42) | TDP1 | |
| SCHEMBL18631712 | 0.73 | TDP1 (0.37) | ADH1AADH1CTDP1 | |
| SCHEMBL4669958 | 0.72 | ADH1A (0.34) | ADH1AADH1CTDP1 | |
| SCHEMBL4673520 | 0.70 | TDP1 (0.34) | ADH1AADH1CTDP1 | |
| SCHEMBL2971810 | 0.70 | TDP1 (0.34) | TDP1 | |
| SCHEMBL4670336 | 0.69 | ADH1A (0.34) | ADH1AADH1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210348081-A1 | METHOD FOR RELEASING ALDEHYDE OR KETONE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2021-11-11 | — | — | US | disclosed |
| EP-3572518-A1 | METHOD FOR RELEASING ALDEHYDE OR KETONE | Takasago International Corporation (JP) | 2019-11-27 | — | — | EP | disclosed |
| US-20190338216-A1 | METHOD FOR RELEASING ALDEHYDE OR KETONE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2019-11-07 | — | — | US | disclosed |
| US-10442821-B2 | Method for releasing unsaturated aldehyde or ketone | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2019-10-15 | — | — | US | disclosed |
| US-20190185494-A1 | METHOD FOR RELEASING UNSATURATED ALDEHYDE OR KETONE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2019-06-20 | — | — | US | disclosed |
| EP-3492570-A1 | METHOD FOR RELEASING UNSATURATED ALDEHYDE OR KETONE | Takasago International Corporation (JP) | 2019-06-05 | — | — | EP | disclosed |
| EP-2438989-B1 | USE OF ASYMMETRIC HYDROGENATION CATALYST | TAKASAGO PERFUMERY CO LTD (JP) | 2016-04-13 | — | — | EP | disclosed |
| US-9061959-B2 | Method for manufacturing optically active menthol | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-06-23 | — | — | US | disclosed |
| US-9000192-B2 | Catalyst for asymmetric hydrogenation and method for manufacturing optically active carbonyl compound using the same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-04-07 | — | — | US | disclosed |
| US-8674144-B2 | Catalyst for asymmetric hydrogenation and method for manufacturing optically active carbonyl compound using the same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-03-18 | — | — | US | disclosed |
| EP-2646150-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION AND METHOD FOR MANUFACTURING OPTICALLY ACTIVE CARBONYL COMPOUND USING THE SAME | Takasago International Corporation (JP) | 2013-10-09 | — | — | EP | disclosed |
| EP-2647616-A1 | METHOD FOR MANUFACTURING OPTICALLY ACTIVE MENTHOL | Takasago International Corporation (JP) | 2013-10-09 | — | — | EP | disclosed |
| US-20130253228-A1 | METHOD FOR MANUFACTURING OPTICALLY ACTIVE MENTHOL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-09-26 | — | — | US | disclosed |
| US-20130217895-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION AND METHOD FOR MANUFACTURING OPTICALLY ACTIVE CARBONYL COMPOUND USING THE SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-08-22 | — | — | US | disclosed |
| EP-2543437-A2 | HOMOGENEOUS ASYMMETRIC HYDROGENATION CATALYST | Takasago International Corporation (JP) | 2013-01-09 | — | — | EP | disclosed |
| US-8217204-B2 | Catalyst for asymmetric hydrogenation | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2012-07-10 | — | — | US | disclosed |
| WO-2012074128-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION AND METHOD FOR MANUFACTURING OPTICALLY ACTIVE CARBONYL COMPOUND USING THE SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2012-06-07 | — | — | WO | disclosed |
| US-20120136176-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION AND METHOD FOR MANUFACTURING OPTICALLY ACTIVE CARBONYL COMPOUND USING THE SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2012-05-31 | — | — | US | disclosed |
| EP-2457655-A2 | Catalyst for asymmetric hydrogenation comprising peptides and method for manufacturing optically active carbonyl compound using the same | Takasago International Corporation (JP) | 2012-05-30 | — | — | EP | disclosed |
| US-20100324338-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2010-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100324338-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION | H1-0, H1-5, ADH5 | ADH1A 72/4885ADH1C 68/4885ADH1B 282/4885 |
| US-20120136176-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION AND METHOD FOR MANUFACTURING OPTICALLY ACTIVE CARBONYL COMPOUND USING THE SAME | HMOX1, HIRA, HRH1 | ADH1A 313/4885ADH1C 186/4885ADH1B 256/4885 |
| US-20130217895-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION AND METHOD FOR MANUFACTURING OPTICALLY ACTIVE CARBONYL COMPOUND USING THE SAME | HMOX1, NQO1, CBR3 | ADH1A 113/4885ADH1C 80/4885ADH1B 105/4885 |
| US-20190185494-A1 | METHOD FOR RELEASING UNSATURATED ALDEHYDE OR KETONE | FAAH2, ALDH1A1, FASN | ADH1A 65/4885ADH1C 73/4885ADH1B 53/4885 |
| US-10442821-B2 | Method for releasing unsaturated aldehyde or ketone | FAAH2, ALDH1A1, FASN | ADH1A 65/4885ADH1C 73/4885ADH1B 53/4885 |
| US-20190338216-A1 | METHOD FOR RELEASING ALDEHYDE OR KETONE | APEH, AKR1C3, AKR7A2 | ADH1A 39/4885ADH1C 28/4885ADH1B 110/4885 |
| US-20130253228-A1 | METHOD FOR MANUFACTURING OPTICALLY ACTIVE MENTHOL | MSMO1, GGPS1, MAN1B1 | ADH1A 252/4885ADH1C 48/4885ADH1B 214/4885 |
| US-20210348081-A1 | METHOD FOR RELEASING ALDEHYDE OR KETONE | APEH, AKR7A2, FAAH2 | ADH1A 46/4885ADH1C 35/4885ADH1B 91/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.